Cyclotron vs generator-produced 68Ga PSMA: a single-institution, prospective clinical trial

Cyclotron vs generator-produced 68Ga PSMA: a single-institution, prospective clinical trial

The clinical utility of gallium 68 (68Ga)-PSMA PET for the diagnosis and management of prostate cancer is driven in part by radioisotope availability and production costs. This study evaluates the equivalence between the two manufacturing processes for 68Ga-PSMA: 68Ga-PSMA-cyclotron (from a solid ta...

Full description

Bibliographic Details
Main Authors: Juana Martinez, Kritika Subramanian, Sandra Huicochea Castellanos, Charlene Thomas, Arindam Roy Choudhury, Brett Muench, Scott T. Tagawa, Naga Vara Kishore Pillarsetty, Joseph R. Osborne
Format: Article
Language:English
Published: Elsevier 2023-02-01
Series:Translational Oncology
Subjects:
68Ga-PSMA
PET/CT
prostate cancer
cyclotron
generator
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523322002522

Internet

http://www.sciencedirect.com/science/article/pii/S1936523322002522

Similar Items